Hedy Kindler to Neurofibromin 2
This is a "connection" page, showing publications Hedy Kindler has written about Neurofibromin 2.
Connection Strength
0.206
-
Reply to K. Masuda et al. J Clin Oncol. 2019 09 01; 37(25):2294-2295.
Score: 0.166
-
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study. J Clin Oncol. 2019 04 01; 37(10):790-798.
Score: 0.040